Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

about

Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.

P2860

Q38915277-58F5320A-D6BA-4F8A-A5FB-F633784B8623

P2860

Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

Item

http://www.wikidata.org/entity/Q38394274

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Gene expression risk signature ...... roarray probe set translation.

@en

type

Item

label

Gene expression risk signature ...... roarray probe set translation.

@en

prefLabel

Gene expression risk signature ...... roarray probe set translation.

@en

P1476

Gene expression risk signature ...... croarray probe set translation

@en

P2093

D L Kristensen

http://www.w3.org/2001/XMLSchema#string

F C Nielsen

http://www.w3.org/2001/XMLSchema#string

M K Andersen

http://www.w3.org/2001/XMLSchema#string

N T Clausen

http://www.w3.org/2001/XMLSchema#string

R Borup

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.

Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease.

International staging system for multiple myeloma.

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

A novel measure of chromosome instability can account for prognostic difference in multiple myeloma.

P304

298-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJLH.12486

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Annette J. Vangsted

N Emil U Hermansen

P Gimsing

P577

2016-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299488770

http://www.w3.org/2001/XMLSchema#string

P698

27027250

http://www.w3.org/2001/XMLSchema#string

Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

about

P2860

P2860

Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698